Abstract
Microarray and deep sequencing technologies have provided unprecedented opportunities for mapping genome mutations, RNA transcripts, transcription factor binding, and histone modifications at high resolution at the genome-wide level. This has revolutionized the way in which transcriptomes, regulatory networks and epigenetic regulations have been studied and large amounts of heterogeneous data have been generated. Although efforts are being made to integrate these datasets unbiasedly and efficiently, how best to do this still remains a challenge. Here we review major impacts of high-throughput genome-wide data generation, their relevance to human diseases, and various bioinformatics approaches for data integration. Finally, we provide a case study on inflammatory diseases.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lander E S, Linton L M, Bruce B, et al. Initial sequencing and analysis of the human genome. Nature, 2001, 409: 860–921
Venter J C, Adams M D, Myers E W, et al. The sequence of the human genome. Science, 2001, 291: 1304–1351
Pennisi E. Breakthrough of the year. Human genetic variation. Science, 2007, 318: 1842–1843
Nielsen R. Genomics: in search of rare human variants. Nature, 2010, 467: 1050–1051
Nik-Zainal S, Alexandrov L B, Wedge D C, et al. Mutational processes molding the genomes of 21 breast cancers. Cell, 2012, 149: 979–993
Pasaniuc B, Rohland N, McLaren P J, et al. Extremely low-coverage sequencing and imputation increases power for genome-wide association studies. Nat Genet, 2012, 44: 631–635
Collins F. Has the revolution arrived? Nature, 2010, 464: 674–675
Servin B, Stephens M. Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet, 2007, 3: e114
Ashley E A, Butte A J, Wheeler M T, et al. Clinical assessment incorporating a personal genome. Lancet, 2010, 375: 1525–1535
Bird A. Perceptions of epigenetics. Nature, 2007, 447: 396–398
Greer E L, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet, 2012, 13: 343–357
Chi P, Allis C D, Wang G G. Covalent histone modifications-miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer, 2010, 10: 457–469
Mann B S, Johnson J R, Cohen M H, et al. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist, 2007, 12: 1247–1252
Sekigawa I, Kawasaki M, Ogasawara H, et al. DNA methylation: its contribution to systemic lupus erythematosus. Clin Exp Med, 2006, 6: 99–106
Maciejewska-Rodrigues H, Karouzakis E, Strietholt S, et al. Epigenetics and rheumatoid arthritis: the role of SENP1 in the regulation of MMP-1 expression. J Autoimmun, 2010, 35: 15–22
Miao F, Smith D D, Zhang L, et al. Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes, 2008, 57: 3189–3198
Amir R E, Van den Veyver I B, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet, 1999, 23: 185–188
Tsankova N, Renthal W, Kumar A, et al. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci, 2007, 8: 355–367
Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of histone methylations in the human genome. Cell, 2007, 129: 823–837
Eckhardt F, Lewin J, Cortese R, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet, 2006, 38: 1378–1385
Hesselberth J R, Chen X, Zhang Z, et al. Global mapping of protein-DNA interactions in vivo by digital genomic footprinting. Nat Methods, 2009, 6: 283–289
Yu H, Zhu S, Zhou B, et al. Inferring causal relationships among different histone modifications and gene expression. Genome Res, 2008, 18: 1314–1324
Xiao S, Xie D, Cao X, et al. Comparative epigenomic annotation of regulatory DNA. Cell, 2012, 149: 1381–1392
Jin C, Li J, Green C D, et al. Histone demethylase UTX-1 regulates C. elegans life span by targeting the insulin/IGF-1 signaling pathway. Cell Metab, 2011, 14: 161–172
Xue H, Xian B, Dong D, et al. A modular network model of aging. Mol Syst Biol, 2007, 3: 147
Zhou B, Yang L, Li S, et al. Midlife gene expressions identify modulators of aging through dietary interventions. Proc Natl Acad Sci USA, 2012, 109: E1201–E1209
Wei G, Wei L, Zhu J, et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity, 2009, 30: 155–167
Wei G, Abraham B J, Yaqi R, et al. Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity, 2011, 35: 299–311
Voineagu I, Wang X, Johnston P, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature, 2011, 474: 380–384
Kang H J, Kawasawa Y I, Cheng F, et al. Spatio-temporal transcriptome of the human brain. Nature, 2011, 478: 483–489
Yang L, Duff M O, Graveley B R, et al. Genomewide characterization of non-polyadenylated RNAs. Genome Biol, 2011, 12: R16
Yin Q F, Yang L, Zhang Y, et al. Long noncoding RNAs with snoRNA ends. Mol Cell, 2012, 48: 219–230
Hvistendahl M. My microbiome and me. Science, 2012, 336: 1248–1250
Snyder M, Du J, Gerstein M. Personal genome sequencing: current approaches and challenges. Genes Dev, 2010, 24: 423–431
Chen R, Mias G I, Li-Pook-Than J, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell, 2012, 148: 1293–1307
Davis B D. The isolation of biochemically deficient mutants of bacteria by means of penicillin. Proc Natl Acad Sci USA, 1949, 35: 1–10
Bedell M A, Jenkins N A, Copeland N G. Mouse models of human disease. Part I: techniques and resources for genetic analysis in mice. Genes Dev, 1997, 11: 1–10
Bedell M A, Largaespada D A, Jenkins N A, et al. Mouse models of human disease. Part II: recent progress and future directions. Genes Dev, 1997, 11: 11–43
Hardouin S N, Nagy A. Mouse models for human disease. Clin Genet, 2000, 57: 237–244
Francis-West P H, Robson L, Evans D J. Craniofacial development: the tissue and molecular interactions that control development of the head. Adv Anat Embryol Cell Biol, 2003, 169:III–VI, 1–138
Wilkie A O, Morriss-Kay G M. Genetics of craniofacial development and malformation. Nat Rev Genet, 2001, 2: 458–468
Allanson J E, O’Hara P, Farkas L G, et al. Anthropometric craniofacial pattern profiles in Down syndrome. Am J Med Genet, 1993, 47: 748–752
Allanson J E, Hennekam R C. Rubinstein-Taybi syndrome: objective evaluation of craniofacial structure. Am J Med Genet, 1997, 71: 414–419
Allanson J E, Cole T R. Sotos syndrome: evolution of facial phenotype subjective and objective assessment. Am J Med Genet, 1996, 65: 13–20
Allanson J E, Hall J G, Hughes H E, et al. Noonan syndrome: the changing phenotype. Am J Med Genet, 1985, 21: 507–514
Beaty T H, Murray J C, Marazita M L, et al. A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4. Nat Genet, 2010, 42: 525–529
Birnbaum S, Ludwig K U, Reutter H, et al. Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24. Nat Genet, 2009, 41: 473–477
Mangold E, Ludwig K U, Birnbaum S, et al. Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate. Nat Genet, 2010, 42: 24–26
Rahimov F, Marazita M L, Visel A, et al. Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip. Nat Genet, 2008, 40: 1341–1347
Boehringer S, van der Lijn F, Liu F, et al. Genetic determination of human facial morphology: links between cleft-lips and normal variation. Eur J Hum Genet, 2011, 19: 1192–1197
Kayser M, de Knijff P. Improving human forensics through advances in genetics, genomics and molecular biology. Nat Rev Genet, 2011, 12: 179–192
Little A C, Jones B C, DeBruine L M. Facial attractiveness: evolutionary based research. Philos Trans R Soc Lond B Biol Sci, 2011, 366: 1638–1659
Meyer-Marcotty P, Alpers G W, Gerdes A B, et al. Impact of facial asymmetry in visual perception: a 3-dimensional data analysis. Am J Orthod Dentofacial Orthop, 2010, 137: 168 e1–e8; discussion 168–169
Albert A M, Ricanek K Jr, Patterson E. A review of the literature on the aging adult skull and face: implications for forensic science research and applications. Forensic Sci Int, 2007, 172: 1–9
Fu Y, Guo G, Huang T S. Age synthesis and estimation via faces: a survey. Pattern Analysis and Machine Intelligence, IEEE Transactions on, 2010, 32: 1955–1976
Bowyer K W, Chang K, Flynn P. A survey of approaches and challenges in 3D and multi-modal 3D+2D face recognition. Comput Vis Image Und, 2006, 101: 1–15
Burton A M, Wilson S, Cowan M, et al. Face recognition in poor-quality video: evidence from security surveillance. Psychol Sci, 1999, 10: 243–248
Poh M Z, McDuff D J, Picard R W. Non-contact, automated cardiac pulse measurements using video imaging and blind source separation. Opt Express, 2010, 18: 10762–10774
Boehringer S, van der Lijin F, Liu F, et al. Genetic determination of human facial morphology: links between cleft-lips and normal variation. Eur J Hum Genet, 2011, 19: 1192–1197
Farkas L G, Katic M J, Forrest C R. International anthropometric study of facial morphology in various ethnic groups/races. J Craniofac Surg, 2005, 16: 615
Weinberg S M, Naidoo S D, Bardi K M, et al. Face shape of unaffected parents with cleft affected offspring: combining three-dimensional surface imaging and geometric morphometrics. Orthod Craniofac Res, 2009, 12: 271–281
Hammond P, Hutton T J, Allanson J E, et al. 3D analysis of facial morphology. Am J Med Genet A, 2004, 126: 339–348
Maal T J, van Looon B, Plooij J M, et al. Registration of 3-dimensional facial photographs for clinical use. J Oral Maxillofac Surg, 2010, 68: 2391–2401
Wan J, Shen L, Fang S, et al. A framework for 3D analysis of facial morphology in fetal alcohol syndrome. In: Proceedings of the 5th International Conference on Medical Imaging and Augmented Reality, 2010. 118–127
Guo J, Mei X, Tang K. Automatic landmark annotation and dense correspondence registration for 3D human face images. arXiv: 1212. 4920
Bhuiyan Z A, Klein M, Hammond P, et al. Genotype-phenotype correlations of 39 patients with Cornelia De Lange syndrome: the Dutch experience. J Med Genet, 2006, 43: 568–575
Hammond P, Hannes F, Suttie M, et al. Fine-grained facial phenotype-genotype analysis in Wolf-Hirschhorn syndrome. Eur J Hum Genet, 2012, 20: 33–40
Hammond P, Hutton T J, Allanson J, et al. 3D dense surface models identify the most discriminating facial features in dysmorphic syndromes. In: 54th Annual Meeting of the American Society for Human Genetics, Toronto, Canada, 2004. 1
Hutton T J, Buxton B F, Hammond P, et al. Estimating average growth trajectories in shape-space using kernel smoothing. IEEE Trans Med Imag, 2003, 22: 747–753
Hammond P, Hutton T J, Allanson J E, et al. Discriminating power of localized three-dimensional facial morphology. Am J Hum Genet, 2005, 77: 999–1010
Hammond P, Forster-Gibson C, Chudley A E, et al. Face-brain asymmetry in autism spectrum disorders. Mol psychiatry, 2008, 13: 614–623
Kasperavičiūtė D, Catarino C B, Chinthapalli K, et al. Uncovering genomic causes of co-morbidity in epilepsy: gene-driven phenotypic characterization of rare microdeletions. PLoS ONE, 2011, 6: e23182
Han J D. Understanding biological functions through molecular networks. Cell Res, 2008, 18: 224–237
Yeger-Lotem E, Riva L, Su L J, et al. Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity. Nat Genet, 2009, 41: 316–323
Chen F, Zhang W, Liang Y, et al. Transcriptome and network changes in climbers at extreme altitudes. PLoS ONE, 2012, 7: e31645
Huang J, Liu Y, Zhang W, et al. eResponseNet: a package prioritizing candidate disease genes through cellular pathways. Bioinformatics, 2011, 27: 2319–2320
Scher J U, Abramson S B. The microbiome and rheumatoid arthritis. Nat Rev Rheumatol, 2011, 7: 569–578
Stahl E A, Raychaudhuri S, Remmers E F, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet, 2010, 42: 508–514
Kochi Y, Okada Y, Suzuki A, et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet, 2010, 42: 515–519
Liu Y, Zhang C, Zhao L, et al. Adapting functional genomic tools to metagenomic analyses: investigating the role of gut bacteria in relation to obesity. Brief Funct Genomics, 2010, 9: 355–361
Fronza R, Tramonti M, Atchley W R, et al. Joint analysis of transcriptional and post-transcriptional brain tumor data: searching for emergent properties of cellular systems. BMC Bioinformatics, 2011, 12: 86
Fronza R, Tramonti M, Atchley W R, et al. Brain cancer prognosis: independent validation of a clinical bioinformatics approach. J Clin Bioinforma, 2012, 2: 2
Wu G, Zhu L, Dent J E, et al. A comprehensive molecular interaction map for rheumatoid arthritis. PLoS ONE, 2010, 5: e10137
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Yang, L., Wei, G., Tang, K. et al. Understanding human diseases with high-throughput quantitative measurement and analysis of molecular signatures. Sci. China Life Sci. 56, 213–219 (2013). https://doi.org/10.1007/s11427-013-4445-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-013-4445-9